The effect of drug pricing on outpatient payments and treatment for three soil-transmitted helminth infections in the United States, 2010-2017

Keyphrases

• United States 100%
• Drug Effects 100%
• Standard of Care 100%
• Drug Pricing 100%
• Soil-transmitted Helminth Infections 100%
• Quality of Care 60%
• Non-drug 60%
• Health Care Costs 40%
• Drug Costs 40%
• Parasitic Infection 40%
• MarketScan 40%
• Mebendazole 40%
• Albendazole 40%
• Drug Treatment 20%
• Prescription Drugs 20%
• Drug Utilization 20%
• Infection Treatment 20%
• Treatment Costs 20%
• Treatment Pathways 20%
• Two-sample T-test 20%
• Outpatient Visits 20%
• Treatment Use 20%
• Outpatient Care 20%
• Prescription Drug Costs 20%
• Medicaid Database 20%
• Commercial Claims 20%
• Hookworm 20%
• Ascariasis 20%
• Trichuriasis 20%
• Antiparasitic Drugs 20%
• First Diagnosis 20%
• Outpatient Cost 20%
• Rising Prices 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• Prescription Drug 100%
• Mebendazole 100%
• Helminthiasis 100%
• Albendazole 100%
• Pharmacotherapy 50%
• Drug Utilization 50%
• Antiparasitic Agent 50%
• Parasitosis 50%
• Ascariasis 50%
• Hookworm 50%
• Trichuriasis 50%

Medicine and Dentistry

• Outpatient 100%
• Helminthiasis 100%
• Health Care Cost 42%
• Prescription Drug 28%
• Mebendazole 28%
• Albendazole 28%
• Infection 14%
• Drug Therapy 14%
• Student T Test 14%
• Parasitic Disease 14%
• Outpatient Care 14%
• Ascariasis 14%
• Infectious Disease Treatment 14%
• Trichuriasis 14%
• Parasitic Disease 14%
• Antiparasitic Agent 14%